According to Robert S. Brown, Jr., MD, MPH, FAASLD, it is a daunting task to review the hundreds of hepatitis-focused abstracts being presented at The Liver Meeting®, but it was a task he was pleased to take on.
“Having an expert clinician review the top papers as well try to bring together thematically the major themes of the meeting has been useful to me as an attendee. I’m honored to have been selected to do it this year as the expert clinician,” said Dr. Brown, Gladys and Roland Harriman Professor of Medicine, Vice Chair of Transitions of Care, and Clinical Chief of the Division of Gastroenterology and Hepatology in the Department of Medicine at Weill Cornell Medical College in New York.
Dr. Brown is an internationally known expert in liver disease and liver transplantation. He has co-authored more than 150 peer-reviewed articles, mostly dedicated to viral hepatitis and liver transplantation, and has extensive research funding in those areas.
There were 469 abstracts to review this year, and Dr. Brown plans to highlight the major advances and themes of the hepatitis research being presented during the meeting.
“I’ll try to focus on the bigger issues in terms of how we are going to apply newer and upcoming treatment regimens into the existing treatment paradigm for hepatitis C, which is a little different from when we had the first wave of new treatments where there were fewer choices,” he said. “There’s also a lot of data on reinfection, and I will try to summarize some of that. I’m hopeful I’ll answer some of the critical questions that people have about their most difficult to treat patients and challenging clinical scenarios.
Dr. Brown hopes that, for those who may miss the key abstract presentations, his presentation will allow them to get a look at the data from a non-biased viewpoint as well as provide a useful overview of the research for clinicians who may not be entirely focused on hepatitis to give them a look at the best of the best science.
“For those of us who work on hepatitis as a major part of our career, even we can’t get to all the key abstracts. This gives a chance for all of us to stay up to date,” he said.
Also, taking place on Tuesday morning is a second debrief session focusing on clinical hepatology presented by Arun J. Sanyal, MD, FAASLD, who is Charles Caravati Professor and Chair of the Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University School of Medicine.
Dr. Sanyal has developed, mediated, and encouraged global liver research as a physician-scientist for 25 years. His medical career has spanned the spectrum of translational science in liver cirrhosis, NASH, and non-alcoholic fatty liver disease (NAFLD), with a particular focus on obesity and cardiovascular effects related to liver disease.
He will review the top science contained in the clinical abstract sessions of The Liver Meeting®.
AASLD President Keith D. Lindor, MD, FAASLD, expects both sessions to be outstanding contributions to the meeting.
“The Hepatitis Debrief has always been popular,” said Dr. Lindor. “The addition of the Clinical Hepatology Debrief will make Tuesday a can’t miss day of the meeting.”
11:30 am – Noon Tuesday
CC: Auditorium and Balcony
Clinical Hepatology Debrief
12:30 pm – 1:00 pm Tuesday
CC: Auditorium and Balcony